drugset / Trial / NCT00644423

Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)

NCT00644423

Completed 18 enrolled Durham VA Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

An increasing literature shows that omega-3 fatty acids provide numerous health benefits, including a variety of psychiatric symptoms and disorders including stress, anxiety, cognitive impairment, mood disorders (major depression and bipolar disorder) and schizophrenia. Omega-3 fatty acids may additionally represent a promising treatment strategy in patients with PTSD. Moreover, given its beneficial cardiovascular effects, adjunctive omega-3 fatty acids may also benefit the general health status of these veterans, who frequently present with a variety of comorbid medical disorders.

Timeline

Start
2008-09-22
Primary completion
2010-07-15
Completion
2010-07-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lovaza Other / unclassified 1650 mg